# Peter Farina

> Peter Farina is a Series B investor at Canaan Partners backing Sensor. See 2 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: Angel Investor
- Fund: [Canaan Partners](https://shizune.co/investors/profile/canaan-partners)
- Location: North Salem, United States
- Total investments: 2
- Last investment: Aug 2016
- Lead investor: 50%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/in/peter-farina-6a88b37/

Peter Farina is a Series B investor at Canaan Partners in North Salem focused on Sensor and Medical. Peter Farina is based out of North Salem, New York and is the Executive in Residence of Canaan. Peter previously worked at Developing World Cures as a CEO. Peter Farina attended the University at Buffalo.

## Contacts

5 contacts available for Peter Farina: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/peter-farina?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Sensor | 1 | 50% |
| Medical | 1 | 50% |
| Biotechnology | 1 | 50% |
| Health Diagnostics | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sample6 | Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours.Its proprietary Bioillumination Platform was developed by Professor Tim Lu (MIT) and Dr. Michael Koeris in the lab of Professor James Collins at the Howard Hughes Medical Institute andBoston University. The platform allows for the engineering of bioparticles that target and “light up” specific unwanted bacteria—or specific groups of bacterial species. They couple this capability with highly sensitive sensor technology that detects low levels of pathogens to see results in minutes—right on-site—with no laboratory required.Sample6′s mission is to improve the health and safety of global consumers by building integrated systems that quickly and easily detect harmful and unwanted bacteria. They see applications in food production, retailing, healthcare, and beyond—anywhere humans and bacteria intersect. | $12.7M | Series C | Aug 22, 2016 |  |
| Sample6 | Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours.Its proprietary Bioillumination Platform was developed by Professor Tim Lu (MIT) and Dr. Michael Koeris in the lab of Professor James Collins at the Howard Hughes Medical Institute andBoston University. The platform allows for the engineering of bioparticles that target and “light up” specific unwanted bacteria—or specific groups of bacterial species. They couple this capability with highly sensitive sensor technology that detects low levels of pathogens to see results in minutes—right on-site—with no laboratory required.Sample6′s mission is to improve the health and safety of global consumers by building integrated systems that quickly and easily detect harmful and unwanted bacteria. They see applications in food production, retailing, healthcare, and beyond—anywhere humans and bacteria intersect. | $13.5M | Series B | Oct 09, 2013 |  |

2 of 2 investments shown.

## Co-investors
- [Cultivian Sandbox Ventures](https://shizune.co/investors/profile/cultivian-sandbox-ventures) — VC Fund, 2 deals together
- [Acre Venture Partners](https://shizune.co/investors/profile/acre-venture-partners) — VC Fund, 1 deal together
- [Chevron Technology Ventures](https://shizune.co/investors/profile/chevron-technology-ventures) — VC Fund, 1 deal together
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund, 1 deal together
- [Founder Collective](https://shizune.co/investors/profile/founder-collective) — VC Fund, 1 deal together
- [The Kraft Group](https://shizune.co/investors/profile/kraft-group) — VC Fund, 1 deal together

## About Canaan Partners

VC Fund · Menlo Park, United States

Canaan is an early stage venture capital firm that invests in entrepreneurs with visionary ideas. With $5B under management, a diversified fund and over 190 exits to date, Canaan has invested in some of the world's leading technology and healthcare companies over the past 30 years. Canaan’s focus areas include fintech, enterprise/cloud,marketplaces, frontier tech, biopharma, digital health, and medtech.

5 contacts available at Canaan Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Deepak Kamra | General Partner | https://shizune.co/investors/profile/deepak-kamra |
| Peter Farina | Executive in Residence | https://shizune.co/investors/profile/peter-farina |
| Bob Williams | VC In Residence | https://shizune.co/investors/profile/bob-williams |
| Brendan Dickinson | General Partner | https://shizune.co/investors/profile/brendan-dickinson |
| Brenton Ahrens | General Partner | https://shizune.co/investors/profile/brent-ahrens |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Peter Farina invest in?

Peter Farina invests primarily in Sensor, Medical and Biotechnology startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Peter Farina?

Public channels for Peter Farina include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Peter Farina last invest?

The most recent investment recorded for Peter Farina closed in Aug 2016. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co